BONESUPPORT - About the company
BONESUPPORT is a public company based in Lund (Sweden), founded in 2000. It operates as an Injectable, synthetic bone substitutes for remodeling. BONESUPPORT has raised $101M in funding from Tellacq Partners. The company has 90 active competitors, including 23 funded and 13 that have exited. Its top competitors include companies like Arsenal Medical, Kerecis and Kuros Biosciences.
Company Details
Bonesupport is a Swedish medical technology company dedicated to the development injectable osteoconductive biomaterials for the treatment of fractures caused by osteoporosis, and bone voids or gaps in bone caused by trauma, disease or related to surgical procedures. Its product CERAMENT manufactured using Calcium Sulphate and Hydroxyapatite combined with liquid Iohexol, with its unique properties, is a biphasic injectable ceramic bone substitute intended for bone voids that mimics the properties of cancellous bone and is replaced by bone during the healing process.
- Website
- www.bonesupport.com/en-eu/
- Email ID
- *****@bonesupport.com
- Phone Number
- +46 **********
- Registered Address
- 6TH FLOOR,9 APPOLD STREET,LONDON,UNITED KINGDOM,EC2A 2AP
Key Metrics
Founded Year
2000
Location
Lund, Sweden
Stage
Public
Total Funding
$101M in 9 rounds
Latest Funding Round
Investors
Ranked
2nd among 90 active competitors
Annual Revenue
£1M - £10M as on Dec 31, 2020
Employee Count
207 as on Sep 30, 2026
Similar Companies
Exit Details
Public
Legal entities associated with BONESUPPORT
BONESUPPORT is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Bonesupport ApS CIN: 40081135 , Denmark, Active | Nov 25, 2018 | - | - | |
BONE SUPPORT UK LTD CIN: 10352673 , United Kingdom, Active | Aug 30, 2016 | £1M - £10M (As on Dec 31, 2020) | 17 (As on Dec 31, 2024) |
BONESUPPORT's IPO details
BONESUPPORT got listed on Jun 22, 2017.
Click here to take a look at BONESUPPORT's IPO in detail
Sign up to download BONESUPPORT's company profile
BONESUPPORT's funding and investors
BONESUPPORT has raised a total funding of $101M over 9 rounds. Its first funding round was on Mar 02, 2006. Its latest funding round was a Series C round on Oct 26, 2016 for $*****. 6 investors participated in its latest round. BONESUPPORT has 17 institutional investors.
Here is the list of recent funding rounds of BONESUPPORT:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 26, 2016 | 7472239 | Series C | 6463979 | 2995008 | 1646079 | 9324351 |
Oct 26, 2016 | 8635770 | Conventional Debt | 4330324 | 7375299 | 5286657 | |
Sep 01, 2016 | 3791405 | Grant (prize money) | 5105973 | 3526071 | 5081845 |
View details of BONESUPPORT's funding rounds and investors
BONESUPPORT's founders and board of directors
Founder? Claim ProfileBONESUPPORT's employee count trend
BONESUPPORT has 207 employees as of Sep 26. Here is BONESUPPORT's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
BONESUPPORT's Competitors and alternates
Top competitors of BONESUPPORT include Arsenal Medical, Kerecis and Kuros Biosciences. Here is the list of Top 10 competitors of BONESUPPORT, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Arsenal Medical 2005, Waltham (United States), Acquired | Developer of polymer-based foams and fibers | $69.9M | 65/100 | |
2nd | BONESUPPORT 2000, Lund (Sweden), Public | Injectable, synthetic bone substitutes for remodeling | $101M | 64/100 | |
3rd | Provider of fish-skin acellular dermal matrix transplantation technology | $93.1M | 63/100 | ||
4th | Kuros Biosciences 2000, Schlieren (Switzerland), Public | Provider of smart solutions for bone disease management | $24.6M | 63/100 | |
5th | ISTO Biologics 1997, St. Louis (United States), Acquired | Developer of treatments for cartilage and bone problems | $40.7M | 63/100 | |
6th | Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma | $19.7M | 61/100 | ||
7th | Cerapedics 1996, Westminster (United States), Series D | Developer of Osteobiologic products | $88.5M | 60/100 | |
8th | Atreon Orthopedics 2016, Hilliard (United States), Series A | Innovating orthopedics with advanced biologic solutions for musculoskeletal healing | $5.42M | 56/100 | |
9th | Locate Bio 2001, Nottingham (United Kingdom), Series A | Developer next generation of orthobiologics products for the treatment of injuries | $31.6M | 46/100 | |
10th | Tetrous 2019, Sherman Oaks (United States), Series A | Manufacturer of demineralized bone fiber implants for surgical enthesis repair | $8.69M | - | 43/100 |
Looking for more details on BONESUPPORT's competitors? Click here to see the top ones
BONESUPPORT's Investments and acquisitions
BONESUPPORT has made no investments or acquisitions yet.
Reports related to BONESUPPORT
Here is the latest report on BONESUPPORT's sector:
News related to BONESUPPORT
Media has covered BONESUPPORT for a total of 7 events in the last 1 year, 2 of them have been about company updates.
•
•
BoneSupport launches share buyback program of up to 100 million Swedish kronorStock Screener•Sep 01, 2026•BONESUPPORT
•
Bonesupport: Redeye keeps valuation unchanged after FDA delayStock Screener•Aug 27, 2026•BONESUPPORT
•
CMS confirms higher DRG reimbursement for Bonesupport's Cerament GStock Screener•Aug 03, 2026•BONESUPPORT
•
Bonesupport Holding AB GAAP EPS of SEK 1.23, revenue of SEK 355.7MSeeking Alpha•Jul 16, 2026•BONESUPPORT
•
Apollo Hospitals Launches Advanced Bone Regeneration Solution for Diabetic and Complex Bone Infections in IndiaBusinessFortNight•May 05, 2026•Apollo Hospitals, BONESUPPORT
•
HealthCap V distributes its holding in BONESUPPORT to its limited partners and general partnerCision•May 26, 2025•Healthcap, BONESUPPORT
•
Immodulon Appoints New Chair and Leadership Team to Drive Late-Stage Clinical Development of IMM-101 in Pancreatic CancerGlobeNewswire•May 10, 2023•Immodulon Therapeutics, BONESUPPORT
•
BONESUPPORT Appoints Michael Roth as General Manager & Executive Vice President Commercial Operations North AmericaPR Newswire•Apr 29, 2020•BONESUPPORT
•
Change in Number of Shares and Votes in BONESUPPORT HOLDING AB (Publ)CMOCRO•Aug 30, 2019•BONESUPPORT
Are you a Founder ?
FAQs about BONESUPPORT
Explore our recently published companies
- Saalfo Tech - Mysuru based, 2016 founded, Unfunded company
- Tolia - Thane based, 1979 founded, Unfunded company
- Krishna's Herbal & Ayurveda - Jodhpur based, 2007 founded, Unfunded company
- Bregma Science - Bengaluru based, 2016 founded, Unfunded company
- http://nordible.co - Unfunded company
- Transformative Biotech - Boulder based, 2023 founded, Unfunded company
